Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]
News [2727]
Articles [201]
Editorials [1]
Conferences [136]
elearning [13]
Inhibiting MDM2 to promote apoptosis in ALL
Prof Binghe Wang - Georgia State University, Atlanta, USA
Inhibiting MDM2 to promote apoptosis in ALL ( Prof Binghe Wang - Georgia State University, Atlanta, USA )
23 Jan 2019
Nivolumab in combination with CIMAvax-EGF for lung cancer
Dr Grace Dy - Roswell Park Cancer Institute, USA
Nivolumab in combination with CIMAvax-EGF for lung cancer ( Dr Grace Dy - Roswell Park Cancer Institute, USA )
4 Jan 2019
Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone...
Dr Mark Bustoros - Harvard Medical School, Boston, USA
Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone in high-risk smouldering multiple myeloma ( Dr Mark Bustoros - Harvard Medical School, Boston, USA )
17 Dec 2018
Indoximod combined with chemotherapy in newly diagnosed AML patients
Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA
Indoximod combined with chemotherapy in newly diagnosed AML patients ( Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA )
17 Dec 2018
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Chemo-immuno combination shows improved PFS when compared with sole...
Prof Leisha Emens - Johns Hopkins Kimmel Cancer, Baltimore, USA
Chemo-immuno combination shows improved PFS when compared with sole chemotherapy treatment in advanced breast cancer ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer, Baltimore, USA )
14 Dec 2018
Association of pathologic complete response following neoadjuvant chemotherapy...
Dr Laura Spring - Harvard Medical School, Boston, USA
Association of pathologic complete response following neoadjuvant chemotherapy with longterm survival in breast cancer ( Dr Laura Spring - Harvard Medical School, Boston, USA )
14 Dec 2018
Results from adding adjuvant capecitabine to treatment for breast cancer...
Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain
Results from adding adjuvant capecitabine to treatment for breast cancer patients ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )
13 Dec 2018
SABCS 2018: Highlights in breast cancer treatment
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2018: Highlights in breast cancer treatment ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
13 Dec 2018
Prognostic value of circulating tumour-cell count in metastatic breast cancer...
Dr Francois-Clement Bidard - Institut Curie, Paris, France
Prognostic value of circulating tumour-cell count in metastatic breast cancer patients ( Dr Francois-Clement Bidard - Institut Curie, Paris, France )
13 Dec 2018
Improved IDFS for breast cancer patients who received trastuzumab emtansine
Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA
Improved IDFS for breast cancer patients who received trastuzumab emtansine ( Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA )
13 Dec 2018
Efficacy and safety of KRd or KCd induction in multiple myeloma
Dr Francesca Gay - University of Torino, Torino, Italy
Efficacy and safety of KRd or KCd induction in multiple myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )
13 Dec 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation